Alexander Tavdidischwili

Director at juta

📍 Germany🔄 Updated September 2026💼 7 investments📅 3 years investing🗓 Last invested Jun 2026
Operator-angel🌍 GermanyInvested this quarter
7
Total investments
5
Early stage
1
Mid stage
0
Late stage
3y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2026
Bayshore was built on the conviction that regulations should be the infrastructure of progress, not its bottleneck. We enable legal and compliance functions in highly regulated enterprises to execute at the speed of business without losing control over risk. For multiple Global 2000 companies, we are teaching AI agents to run complex legal and compliance processes and collaborate with human experts where necessary. By translating legal rules into code, we are shifting the paradigm. AI agents work with the determinism of legal rules instead of relying solely on the probabilistic nature of LLMs. This makes them accurate, explainable, and auditable. # Imprint bayshore AI GmbH Theresienstraße 43 80333 Munich Germany Managing directors: Paul F. Welter, Philipp Wiegand, Erik Krauter. Registered with the commercial register of Munich Local Court under HRB 302926. VAT ID: DE400208363
Investor
Feb 2026
limetax ist eine Gruppe moderner Steuerkanzleien. Wir schaffen die technologische und organisatorische Basis, damit unsere Partnerkanzleien Unternehmen transparent und wirksam beraten können. Für Beratung wie sie sein muss.
Investor
Jan 2026
Lette is an AI command centre that doubles your NOI by running your property portfolio intelligently. We do this by removing operational friction and unlocking revenue streams that never existed before. Helping you run your assets on autopilot, delight residents, and give investors real clarity.
Investor
May 2025
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics. Our discovery platform, Polaris™, applies multimodal AI to clinical data, identifying prognostic and predictive biomarkers that enable more equitable and individualized treatment strategies across solid-tumor cancers. Polaris™ Breast, the company’s first diagnostic, assesses metastatic risk in early breast cancer directly from digitized histology slides, supporting better treatment decisions. Retrospectively validated on thousands of patients from Phase III trials and real-world clinical settings, Polaris™ Breast is available for research use only and is undergoing regulatory approval in the EU and US.
Investor
Mar 2025
At Ingestro, we believe no implementation or services team should waste time and resources manually migrating customer data. That’s why we push the boundaries of today’s technology through AI innovation, helping companies across HR, payroll, procurement, and beyond organize, validate, and clean data from Excel, CSV, XML, and other sources at scale. SaaS leaders such as Factorial, HiBob, and Edenred rely on Ingestro to automate complete data migration workflows, saving up to 90% of their time and enabling their implementation and services teams to focus on growth. The fine print matters too, which is why we maintain ISO 27001 certification and uphold industry-leading security standards. See our Privacy Policy for more details: https://ingestro.com/privacy-policy
Investor
2023
Lio has processed billions of data points to become the best procurement assistant in the world. The AI works 24/7 to help you automate the daily procurement business so that your team can focus on strategic decisions. Lio automatically converts purchase requests into orders - the procurement department doesnt need to be involved. Our AI Agents also support procurement teams by automating daily routine activities. The AI imitates the operational work required for procurement processes and acts like a team member for strategic tasks - directly boosting productivity and saving costs. Enterprise level security. GDPR compliant.
Experience · 8 entries
All (8)
Investments (7)
Founder (1)
2026
Investor
Jun 2026
Bayshore was built on the conviction that regulations should be the infrastructure of progress, not its bottleneck. We enable legal and compliance functions in highly regulated enterprises to execute at the speed of business without losing control over risk. For multiple Global 2000 companies, we are teaching AI agents to run complex legal and compliance processes and collaborate with human experts where necessary. By translating legal rules into code, we are shifting the paradigm. AI agents work with the determinism of legal rules instead of relying solely on the probabilistic nature of LLMs. This makes them accurate, explainable, and auditable. # Imprint bayshore AI GmbH Theresienstraße 43 80333 Munich Germany Managing directors: Paul F. Welter, Philipp Wiegand, Erik Krauter. Registered with the commercial register of Munich Local Court under HRB 302926. VAT ID: DE400208363
Investor
Feb 2026
limetax ist eine Gruppe moderner Steuerkanzleien. Wir schaffen die technologische und organisatorische Basis, damit unsere Partnerkanzleien Unternehmen transparent und wirksam beraten können. Für Beratung wie sie sein muss.
Investor
Jan 2026
Lette is an AI command centre that doubles your NOI by running your property portfolio intelligently. We do this by removing operational friction and unlocking revenue streams that never existed before. Helping you run your assets on autopilot, delight residents, and give investors real clarity.
2025
Investor
May 2025
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics. Our discovery platform, Polaris™, applies multimodal AI to clinical data, identifying prognostic and predictive biomarkers that enable more equitable and individualized treatment strategies across solid-tumor cancers. Polaris™ Breast, the company’s first diagnostic, assesses metastatic risk in early breast cancer directly from digitized histology slides, supporting better treatment decisions. Retrospectively validated on thousands of patients from Phase III trials and real-world clinical settings, Polaris™ Breast is available for research use only and is undergoing regulatory approval in the EU and US.
Investor
Mar 2025
At Ingestro, we believe no implementation or services team should waste time and resources manually migrating customer data. That’s why we push the boundaries of today’s technology through AI innovation, helping companies across HR, payroll, procurement, and beyond organize, validate, and clean data from Excel, CSV, XML, and other sources at scale. SaaS leaders such as Factorial, HiBob, and Edenred rely on Ingestro to automate complete data migration workflows, saving up to 90% of their time and enabling their implementation and services teams to focus on growth. The fine print matters too, which is why we maintain ISO 27001 certification and uphold industry-leading security standards. See our Privacy Policy for more details: https://ingestro.com/privacy-policy
Show all 8 entries ↓
Investment activity
2023–2026 · 7 investments
202322025220263
Recent (last 2 years)Earlier